Key Takeaways
- A brutal year, framed as a cleaning year: Agrochemical prices fell 30–50% across products, high-cost inventory piled up industry-wide, and the pigment division was hit by liquidation of expensive stock. Management calls it an "improvisation year" that will separate survivors from the rest.
- TiO2 is the big bet, now in trial: Phase one of the 16,500-tonne TiO2 plant commenced in Q4, with continuous production, customer sampling, and initial sales underway. Management is "100% successful" confident, but approvals and contracts are still pending.
- Nano Urea could be a multi-year disruptor: A new subsidiary, Meghmani Crop Nutrition, will commission a Nano Urea plant by Q4 FY24. Management is very bullish, citing a government target to replace 0.9 crore tonnes of urea imports, but farmer acceptance will take 2–3 years.
- Near-term pain is priced in, recovery promised from Q2: Q1 FY24 will be challenging; high-cost inventory should clear by mid-Q2, with H2 expected to be much better. FY24 utilization is still seen above 70% across both segments.
- What to watch next quarter: Whether the promised Q2 inventory clearance and demand recovery actually materialize, the pace of TiO2 customer approvals and contract signings, and any further fire or safety incidents after three in three years.
The Downturn: Price Collapse & Inventory Overhang
- Price destruction was broad and deep: Product prices across chemicals and agrochemicals dropped 30% to 45–50% depending on the product, including the key molecule 2,4-D. This was an industry-wide phenomenon, not company-specific.
- High-cost inventory amplified the pain: An industry-wide oversupply of high-cost inventory pressured both revenue and margins. The company responded by cutting agrochemical production 10–11% YoY in Q4 rather than building more expensive stock into a sluggish demand environment.
- Raw material relief provides a partial offset: Raw material prices have come down significantly from earlier highs, and logistics costs have returned to pre-COVID levels, cushioning the price-drop impact on margins.
- The pigment division suffered a double hit: Performance was impacted by liquidation of high-cost inventory, though urea, a major raw material, has come down drastically over the last couple of months, and quarter-on-quarter improvement is already visible.
- Finance costs swung wildly on currency: Huge currency volatility produced an MTM gain of INR 76 crore on receivables (other income) and an MTM loss of INR 46 crore on foreign currency borrowing (finance cost), creating noise in the reported numbers.
Patel: "We consider this as improvisation year and the cleaning year so. It's a good thing that the industry, whoever will be capable enough, will survive and will improve upon. If you are not capable enough, then you will always keep on crying and so it's going to be tough for a few companies I'm sure, but we are very optimistic for this period."
TiO2: The Big Bet Enters Trial Phase
- Phase one is live, but early: The 16,500-tonne sulphate-process TiO2 plant commenced in Q4 FY23 and is under trial run. Continuous production is ongoing, sampling is happening with different customers, and some sales have already begun.
- The stabilization timeline is near-term: Management expects process parameters to be set by May end, with quality and consumption norms stabilizing by June 2023. No big contracts or orders exist yet; the priority is getting product approved at different customer levels.
- Cost structure is being built for advantage: A captive power plant is being installed, which management says will make power and steam costs "drastically low." Ilmenite, the key raw material, has dropped from Rs 44–45 to nearly Rs 28.
- Demand visibility comes from India's paint boom: The domestic paint segment is growing double digits, with large corporates like JSW, MRF, Grasim, and Pidilite entering the market. India imports more than 200,000 tons of TiO2, creating a large substitution opportunity.
- Management is unwilling to share technical detail: When analysts asked for the TiO2 cost structure breakdown or ilmenite consumption per kg, management declined, calling it technical detail they do not normally share.
- Margin expectations are grounded in cycle history: Management analyzed TiO2 prices over 8–10 years, focusing on the delta between raw material and sales price. In good times, margins exceed 20%; the average range is 15–18%.
Patel: "We are technocrat people, we don't consider any kind of failure. So no matter what kind of challenges are going to be there, we will make it 100% successful."
Nano Urea: A Multi-Year Disruption Play
- A new subsidiary signals strategic intent: Meghmani Crop Nutrition Limited has been formed and will be a "very big vertical," introducing many more products in the Nano segment beyond just Nano Urea over the coming years.
- The government mandate creates a large addressable market: India imports close to 0.9 crore tonnes of urea, and the government has set a target of zero urea imports in the next three years. Nano Urea is the designated replacement technology, and Meghmani will be one of the companies alongside IFFCO executing this shift.
- The plant timeline is Q4 FY24: Management hopes to commission the Nano Urea plant by Q4 FY24. Margins will be "much better than 15% for sure," but precise clarity will only come once commercial production starts.
- Farmer adoption is the real bottleneck: Management acknowledges that convincing farmers a 500 ml bottle can replace a 45 kg bag is "not going to be that easy." Significant trials and demonstrations are underway, and a mental shift is expected over the next 2–3 years.
- The marketing strategy bundles compatibility: Compatibility trials of all agrochemicals with Nano Urea have already been completed and are positive. The pitch to farmers will be a single spray combining both products, saving spraying cost without increasing total expense.
- Nano Urea will replace ~50% of conventional urea, not all: Conventional urea will still be used during plantation; Nano Urea will be applied afterward. Management sees a 50% reduction in urea usage as achievable with "fantastic results."
Patel: "India imports close to 0.9 crore tonnes of urea and the government has taken the target that in next three years. They want to make it completely zero import of the Urea. Now you can understand the 0.9 crore tonnes of will be replaced by Nano Urea. So we will be one of the companies along with IFFCO helping the nation and growing together."
Multi-Purpose Plant & New Product Ramp-Up
- New products are in commercial production: Backward-integrated Flubendamide, Cyfluthrin, Beta Cyfluthrin, Spiromesifen, and Ethiprole commenced commercial production during FY23, catering to both domestic and export markets. The plant is still stabilizing.
- The ramp-up path is gradual: Management expects ~50% capacity utilization in the first year, ~65% in the second, and 75–80%+ from the third year onwards. These new products are expected to generate revenue close to INR 650–700 crore.
- No incremental CapEx is needed for that revenue: The new campus already has good infrastructure. Future growth will require only small CapEx to multiply revenue "very fast," per management.
- The $100 million agrochemical contract is already live: Production has commenced, business has started, and all required registrations are in place. The contract is equally distributed over 5 years, give or take 10%.
Margins, Mix & the Formulation Story
- Agrochemicals held up better than pigments: The agrochemicals division delivered an EBITDA margin of nearly 19.6% for FY23, only slightly down from 20.2% last year, despite industry headwinds. The overall company EBITDA margin of 14.2% was dragged down by the pigment segment.
- The long-term agrochemical margin target is ~20%: Management is "very hopeful" of generating ~20% EBITDA margin in the long run.
- Pigment margins should recover to 5–7%: Management is hopeful of returning to that range, but Q1 FY24 is described as "critical and tough."
- Formulation revenue share is stable, not shrinking: Formulations currently contribute ~25–30% of revenue. Management targets good growth in formulations but says the technical business is also growing in parallel, so the percentage should remain in this range and "will never go down."
- Backward integration is non-negotiable, even in downturns: Management will not opportunistically stop backward integration to buy intermediates from outside when times are tough, because chemical plants need to run continuously.
Patel: "We cannot be opportunistic where in the tough time we stop the backward integration and buy the intermediate from outside. When the time is good, you start again manufacturing these are all chemical plants. You need to continuously run those plants no matter what the situation."
Safety, Incidents & Operational Resilience
- Three fire incidents in three years is a pattern: Two incidents occurred in the warehouse, and the company has now taken measures on inventory, safety, and electrification. The most recent fire on 16 April is still under assessment, with an estimated loss of INR 7–8 crore and no adjustment yet made in the financials.
- The agrochemicals division earned Responsible Care® certification: This certification applies to the agrochemicals area. In the pigment area, the company has started working significantly, analyzing where things are going wrong, and hiring experts. Management says it is "very serious" about improving EHS.
- Automation is the answer to human error: The majority of critical operations have been converted to automation. Previous insurance claims have all been settled with no rejections.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Inventory clearance | High-cost inventory cleared, demand environment improves | By middle of Q2 FY24 |
| TiO2 plant stabilization | Process parameters set (Phase 1); quality and consumption norms stabilized (Phases 2 & 3) | End-May 2023; June 2023 |
| Nano Urea plant commissioning | Plant commissioned and commercial production begins | Q4 FY24 |
| MPP revenue ramp-up | Revenue close to INR 650–700 crore from new products | Over 3 years (~50% utilization in Year 1, ~65% in Year 2, 75–80%+ in Year 3) |
| FY24 utilization | More than 70% utilization across both segments | FY24 as a whole |
| Pigment margin recovery | Return to 5–7% EBITDA margin | FY24 (Q1 described as critical and tough) |
| Demerger of pigment and agrochemical businesses | Unlock value for investors when both businesses are significantly big | Over next 2–3 years |
Key Metrics
| Metric | Q4 FY23 |
|---|---|
| Revenue | ₹2,557 cr, +2.5% (FY23 full year) |
| EBITDA | ₹364 cr (FY23 full year) |
| EBITDA margin | 14.2% (FY23 full year) |
| Net profit | ₹250 cr (FY23 full year) |
| Agrochemicals EBITDA margin | 19.6% (FY23), vs 20.2% last year |
| Agrochemicals revenue share | 76% of FY23 revenue |
| Pigments revenue share | 26% of FY23 revenue |
| Cash and cash equivalents | ₹59 cr as on 31st March 2023 |
| Debt to equity ratio | 0.42 as on 31st March 2023 |
| ROCE | ~14% (FY23) |
| ROE | ~16% (FY23) |
| Final dividend | 140% for FY23 |
| MTM gain on receivables | ₹76 cr, shown as other income |
| MTM loss on foreign currency borrowing | ₹46 cr, shown as finance cost |
| Average cost of debt | ~3.5% |
| Multi-purpose plant expected revenue | ₹650–700 cr from new products |
| Multi-purpose plant utilization ramp | ~50% first year, ~65% second year, 75–80%+ third year onwards |
| Nano Urea plant capex | ~₹150 cr |
| Nano Urea plant capacity | 5 cr bottles per year |
| Nano Urea market price | ₹210–225 per bottle (sold by IFFCO) |
| Nano Urea revenue potential | ~₹1,000 cr (management's illustrative math) |
| TiO2 price | nearly ₹190 plus, moving towards ₹200; was as low as ₹160 |
| Ilmenite price | nearly ₹28, down from ₹44–45 |
| TiO2 margin range | 15–18% average, >20% in good times |
| Formulation business revenue share | 25–30% |
| $100 mn agrochemical contract | Equally distributed over 5 years, ±10% |
| Fire incident estimated loss | ₹7–8 cr (16 April 2023, under assessment) |
| Promoter shareholding | Below 50% |